Christopher Gilmore, MD
Pain Medicine · Winston Salem, NCNPI 1225245707
Payments from drug & device makers
Across 989 payments — averaging $1295.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$682K
- MML US, Inc.$364K
- Saluda Medical Americas, Inc.$85K
- Nalu Medical, Inc.$44K
- Nevro Corp.$34K
- Biodelivery Sciences International, Inc.$19K
- plus $53K from 27 others
Across 4 payments — averaging $22.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$89
What the payments were for
- Consulting fees$290,38164%
- Speaking & faculty fees$38,1808%
- Travel & lodging$57,27613%
- Food & beverage$61,45513%
- Education$9,7142%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 287 | $681,768 |
| MML US, Inc. | 73 | $363,827 |
| Saluda Medical Americas, Inc. | 151 | $85,170 |
| Nalu Medical, Inc. | 29 | $44,216 |
| Nevro Corp. | 66 | $33,500 |
| Biodelivery Sciences International, Inc. | 57 | $19,179 |
| Vertex | 7 | $14,755 |
| Painteq LLC | 32 | $11,408 |
| Boston Scientific | 166 | $8,939 |
| Biotronik Inc. | 8 | $6,635 |
| Si-bone, Inc. | 12 | $3,775 |
| Abbott | 18 | $3,193 |
| Biotronik NRO, Inc. | 17 | $2,582 |
| Vertiflex, Inc. | 11 | $571 |
| Spinal Simplicity, LLC | 5 | $435 |
| Collegium Pharmaceutical, Inc. | 20 | $345 |
| Stimwave Technologies Incorporated | 2 | $157 |
| Medtronic(2 entities) | 4 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $62 |
| GRT US Holding, Inc. | 1 | $58 |
| Daiichi Sankyo Inc. | 4 | $53 |
| Redhill Biopharma Inc. | 2 | $39 |
| Pacira Therapeutics, Inc. | 2 | $33 |
| MDD US Operations, LLC | 2 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $22 |
| Globus Medical | 1 | $20 |
| AbbVie | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Forte Bio-pharma LLC | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Shionogi Inc | 1 | $14 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$267,061
- Evoke SCS$48,295
- Senza Spinal Cord Stimulation System$30,986
- Evoke$23,936
- Nalu Neurostimulation System$21,874
- BELBUCA$18,031
- PAINTEQ$10,739
- WAVEWRITER ALPHA$5,322
- IFUSE IMPLANT SYSTEM$3,258
- Prospera$2,227
- Omnia$1,250
- Proclaim Family of SCS IPGs$1,004
- GENERAL PAIN MANAGEMENT$651
- ETERNA$444
- Edora 8 DR-T$336
- BioMonitor$336
- Acticor 7 VR-T DX$336
- Rivacor 7 DR-T$336
- Solia$336
- HA MINUTEMAN G3-R$268
How this compares
$1,280,937 in reported general payments places this provider in the 95th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 31 | $27,921 |
| Xtampza ErOxycodone Myristate | 34 | $17,385 |
| NucyntaTapentadol Hcl | 16 | $16,945 |
| Buprenorphine | 33 | $8,734 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 174 | $4,778 |
| Diclofenac Sodium | 26 | $3,153 |
| Pregabalin | 128 | $2,373 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 127 | $2,294 |
| Gabapentin | 119 | $1,894 |
| Tramadol Hcl ErTramadol Hcl | 16 | $1,333 |
| Naloxone Hcl | 19 | $1,139 |
| Oxycodone Hcl | 91 | $1,080 |
| Duloxetine Hcl | 84 | $1,006 |
| Tizanidine Hcl | 62 | $872 |
| Cephalexin | 72 | $792 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta | $345 | $62,25081 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 182 pain medicine providers in North Carolina.
Other pain medicine in Winston Salem
- Leonardo KapuralWinston Salem$4.1M
- James NorthWinston Salem$3.7M
- Richard RauckWinston Salem$1.7M
- Jeffrey PeacockWinston Salem$553K
- Daniel BintrimWinston Salem$39K
- Lauren BeaverWinston Salem$11K
- Binit ShahHuntersville$863K
- Courtney AumanJacksonville$210K
- Javid BakshAsheville$202K
- David ZubLeland$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.